By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Elite Pharmaceuticals, Inc. 

165 Ludlow Avenue

Northvale  New Jersey  07647  U.S.A.
Phone: 201-750-2646 Fax: 201-750-2755



Company News
Elite Pharma (ELI) Announces Development And License Agreement With Sungen Pharma 8/29/2016 8:12:21 AM
Elite Pharma (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2017 And Provides Conference Call Information 8/10/2016 10:39:44 AM
Elite Pharma (ELI) Files ANDA To Market Generic Percoce 8/10/2016 7:57:32 AM
Elite Pharma (ELI) To Host Conference Call To Discuss SequestOx Complete Response Letter On Monday, July 18, 2016 At 8:30 AM EDT 7/18/2016 8:49:07 AM
Elite Pharma (ELI) Release: FDA Issues Complete Response Letter for SequestOx New Drug Application 7/18/2016 8:47:20 AM
Elite Pharma (ELI) Reports Financial Results For The Fiscal Year Ended March 31, 2016 And Provides Conference Call Information 6/16/2016 10:47:41 AM
Elite Pharma (ELI) To Present SequestOx Data At The American Pain Society 35th Annual Scientific Meeting 5/9/2016 10:29:25 AM
Elite Pharma (ELI) Appoints Davis S. Caskey To Its Board Of Directors 5/4/2016 7:44:53 AM
Elite Pharma (ELI) Announces Changes To Their Board Of Directors 4/12/2016 8:04:47 AM
Elite Pharma (ELI) Announces U.S. FDA Priority Review Designation For Sequestox NDA 3/17/2016 8:02:32 AM